Sphere Fluidic’s picodroplet technology makes it possible to encapsulate and screen millions of individual cells or biological molecules in a single day. Its CytoMine proprietary microfluidic technology allows the ultra-high throughput analysis of isolated cells and generation of their genetic, transcriptomic and proteomic profiles in miniaturised (pL to nL) picodroplets.